In This Article:
Despite escalating global trade tensions, international investments are still a critical component of a well-rounded and balanced portfolio.
International companies GlaxoSmithKline (NYSE: GSK), Netease (NASDAQ: NTES), and Alibaba (NYSE: BABA) may not be household names for most Americans, but they're worth a look for U.S. investors.
Image source: Getty Images.
A new consumer healthcare giant
George Budwell (GlaxoSmithKline): GlaxoSmithKline recently launched a massive joint venture with Pfizer (NYSE: PFE) to form the world's largest consumer healthcare company, potentially paving the way for a far broader distribution of its top-selling brands.
Glaxo owns 68% of the newly minted joint venture, with Pfizer owning the remaining 32%. The combined entity is expected to post annual sales north of $12.7 billion at current exchange rates and it should come to dominate several key consumer healthcare consumer markets such as pain relief, vitamin supplements, respiratory care, and oral care.
Unfortunately, investors can't invest directly in this new healthcare behemoth -- at least not yet. In short, Glaxo plans on eventually spinning off its consumer healthcare unit, but this next step in the process may not occur for up to three years.
The good news is that American investors can buy Glaxo's shares in anticipation of this potentially lucrative consumer healthcare spinoff. By carving out its consumer healthcare unit, Glaxo should realize substantial cost savings and generate a much stronger growth profile, arguably two very good reasons to consider buying the drugmaker's stock now.
The downside is that Glaxo's monstrous dividend yield of 4.5% will probably be one of the first casualties of this spinoff. Glaxo, after all, will be giving up a sizable chunk of its revenue stream by spinning off its consumer healthcare unit.
Team-ups will expand this video game company's reach
Keith Noonan (NetEase): If you play video games, there's a good chance that you'll be seeing a lot more from Chinese video game developer NetEase in the not-too-distant future. The company has teamed up with Activision Blizzard for Diablo Immortal -- an upcoming installment of the popular franchise for mobile devices that could reach a big audience, and it's making additional moves to build its audience in the Western market.
The Chinese game maker recently opened a new development studio in Montreal that will focus on expanding the company's reach in North America, and there's a good chance that video game fans will become much more familiar with the company's output. In an earnings call that took place last November, NetEase Chief Financial Officer Charles Yang had this to say: "Out of the three largest online games markets in the world, we now have reached critical acclaim in two: China and Japan. The United States market is the next frontier for NetEase."